Zusammenfassung
Blutungen während der Schwangerschaft sind oft fulminant und für Mutter und Kind vital bedrohlich. Sie sind für etwa 25% aller peripartalen maternen Sterbefälle verantwortlich. Die besondere Pathophysiologie der schwangerschaftsbedingten hämostaseologischen Veränderungen, wie das erhöhte Gerinnungspotenzial, eine verminderte antikoagulatorische Aktivität und starke Alterationen des fibrinolytischen Systems, müssen dem Behandlungsteam bekannt sein, um eine zielgerichtete, konsequente und interdisziplinäre Therapie durchführen zu können. Zu den wichtigsten therapeutischen Eckpfeilern bei peripartalen Blutungen zählen neben der kausalen gynäkologischen Therapie die frühzeitige Detektion und Durchbrechung einer Hyperfibrinolyse, die Optimierung von Fibrinogen und Thrombozyten als Endstrecke der Gerinnung und die Kenntnis der Möglichkeiten einer erweiterten Gerinnungstherapie.
Abstract
Hemorrhaging during pregnancy is often fulminant and life-threatening for mother and child. Of maternal deaths occurring during pregnancy, 25% are caused by hemorrhaging. All physicians involved in the interdisciplinary treatment of hemorrhaging during pregnancy need to be familiar with the specific pathophysiology of hemostatic changes during pregnancy, e.g. elevated hemostatic capacity, reduced anti-coagulation activity and severe alterations of the fibrinolysis system. Therapists must be able to perform a consequent, goal-directed interdisciplinary approach to prevent adverse maternal and fetal outcomes. The major issues of therapy are causal obstetric treatment of the bleeding, early detection and therapy of hyperfibrinolysis, optimization of fibrinogen and platelet levels and knowledge of the possibilities of a targeted coagulation therapy.
Literatur
Ananth CV, Savitz DA (1994) Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Paediatr Perinat Epidemiol 8: 62–78
Astermark J, Donfield SM, DiMichele DM et al. (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109: 546–551
Axelsen SM, Henriksen TB, Hedegaard M et al. (1995) Characteristics of vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 63: 131–134
Biron-Andreani C, Morau E, Schved JF et al. (2003) Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 33: 170–171
Bonn C, Wetzka B, Zahradnik HP (2002) The use of TEG with the roTEG in preeclampsia and HELLP syndrome. Hypertens Pregnancy [Suppl 1] 21: 80
Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153–168
Catena C, Zingaro L, Casaccio D et al. (2000) Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109: 556–561
Charbit B, Mandelbrot L, Samain E et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5: 266–273
Chowdhury P, Saayman AG, Paulus U et al. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125: 69–73
Clenney TL, Viera AJ (2004) Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ 329: 270–272
Collins PW (2003) Management of acquired haemophilia A – more questions than answers. Blood Coagul Fibrinolysis [Suppl 1] 14: S23–S27
Crochetiere C (2003) Obstetric emergencies. Anesthesiol Clin North Am 21: 111–125
Deneux-Tharaux C, Carmona E, Bouvier-Colle MH et al. (2006) Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 108: 541–548
Dildy GA (2002) Postpartum hemorrhage: new management options. Clin Obstet Gynecol 45: 330–344
Eder AF, Herron R, Strupp A et al. (2007) Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47: 599–607
FitzGerald MP, Floro C, Siegel J et al. (1996) Laboratory findings in hypertensive disorders of pregnancy. J Natl Med Assoc 88: 794–798
Fonseca JE, Mendez F, Catano C et al. (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193: 1591–1598
Franchini M (2006) Postpartum acquired factor VIII inhibitors. Am J Hematol 81: 768–773
Franchini M, Lippi G, Franchi M (2007) The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114: 8–15
Fuchs AR, Romero R, Keefe D et al. (1991) Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165: 1515–1523
Gai MY, Wu LF, Su QF et al. (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112: 154–157
Gerbasi FR, Bottoms S, Farag A et al. (1990) Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 75: 385–389
Goldszmidt E, Davies S (2003) Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth 50: 917–921
Green D (2006) The management of acquired haemophilia. Haemophilia [Suppl 5] 12: 32–36
Hansch E, Chitkara U, McAlpine J et al. (1999) Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 180: 1454–1460
Hardy JF, Moerloose P de, Samama CM (2006) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth [Suppl 6] 53: S40–S58
Hatzopoulos FK (2005) Obstetric drug therapy. In: Koda-Kimble MA, Young LY, Kradjan WA et al. (eds) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia, p 126
Hay CR, Brown S, Collins PW et al. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133: 591–605
Heilmann L, Wild C, Hojnacki B et al. (2006) Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 12: 227–229
Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54: 787–790
Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125–130
Holmes VA (2003) Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 62: 479–493
Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33: 428–432
Huch A, Chaoui R (2004) Sectio caesarea: In: SchneiderH, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe, 2. Aufl. Springer, Berlin Heidelberg New York
Kam PC, Thompson SA, Liew AC (2004) Thrombocytopenia in the parturient. Anaesthesia 59: 255–264
Karalapillai D, Popham P (2007) Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16: 29–34
Kobayashi T, Terao T, Maki M et al. (2001) Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 27: 161–167
Koscielny J, Tempelhoff GF von, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166
Kretzschmar M, Zahm DM, Remmler K et al. (2003) „Anaphylactoid syndrome of pregnancy“ Pathophysiologische und therapeutische Aspekte der Fruchtwasserembolie („anaphylactoid syndrome of pregnancy“) anhand einer Kasuistik mit letalem Ausgang. Anaesthesist 52: 419–426
Krumnikl JJ, Böttiger BW, Strittmatter HJ et al. (2002) Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage. Acta Anaesthesiol Scand 46: 1168–1170
Ku DH, Arkel YS, Paidas MP et al. (2003) Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90: 1074–1079
Letsky EA (2001) Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15: 623–644
Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70: 238–240
Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49: 836–843
Ojala K, Perala J, Kariniemi J et al. (2005) Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 84: 1075–1080
Orlikowski CEP, Rocke DA, Murray WB et al. (1996) Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 77: 157–161
Parnas M, Sheiner E, Shoham-Vardi I et al. (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128: 163–168
Pelage J-P, Le Dref O, Jacob D et al. (1999) Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 78: 698–703
Pfanner G, Kilgert K (2006) Geburtshilfliche Blutungskomplikationen. Hämostaseologie [Suppl 1] 26: S56–S63
Poe MF (1959) Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 20: 825–829
Prabu P, Parapia LA (2006) Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 28: 198–201
Ramanathan J, Bennett K (2003) Pre-eclampsia: fluids, drugs, and anesthetic management. Anesthesiol Clin North Am 21: 145–163
Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46: 1243–1249
Roberts HR, Monroe DM, Oliver JA et al. (1998) Newer concepts of blood coagulation. Haemophilia 4: 331–334
Rouse DJ, MacPherson C, Landon M et al. (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108: 891–897
Schuurmans N, Mackinnin C, Lane C et al. (2000) Prevention and management of postpartum haemorrhage. J Soc Obstet Gynaecol Can 88: 271–281
Segal S, Shemesh IY, Blumenthal R et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268: 266–267
Shafi T, Jeha MT, Black L et al. (1997) Severe aquired haemophilia A treated with recombinant factor VIIa. Br J Haematol 98: 910–912
Sharma SK, Philip J, Whitten CW et al. (1999) Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography. Anesthesiology 90: 3485–3490
Silliman CC, Curtis BR, Kopko PM et al. (2007) Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109: 1752–1755
Smith JG, Merrill DC (2006) Oxytocin for induction of labor. Clin Obstet Gynecol 49: 594–608
Sobieszczyk S, Breborowicz GH, Platicanov V et al. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 85: 1239–1247
Toy P, Popovsky MA, Abraham E et al. (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33: 721–726
UNFPA (2003) Maternal mortality update 2002: a focus on emergency obstetric care. United Nations Population Fund, New York
Vincent J-L, Rossaint R, Riou B et al. (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: a European perspective. Crit Care 10: 1–12
Weiner CP (1986) The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13: 705–717
Whitta RK, Cox DJ, Mallett SV (1995) Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 74: 464–468
Xenakis EM, Piper JM (1997) Chemotherapeutic induction of labour. A rational approach. Drugs 54: 61–68
Yang J, Savitz DA, Dole N et al. (2005) Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol 19: 276–283
Zelop CM, Harlow BL, Frigoletto FD (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168: 1443–1448
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin:
Vorträge bei Veranstaltungen von CSL Behring.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hofer, S., Schreckenberger, R., Heindl, B. et al. Blutungen während der Schwangerschaft. Anaesthesist 56, 1075–1090 (2007). https://doi.org/10.1007/s00101-007-1261-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-007-1261-2
Schlüsselwörter
- Schwangerschaftshämostase
- Blutungen während Schwangerschaft
- Hyperfibrinolyse
- Uterusatonie
- Gerinnungstherapie